Trials / Unknown
UnknownNCT03367559
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
An Open Label Study to Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® (Live Attenuated Rotavirus Vaccine) as a 3-dose Series in Healthy Infants Aged Between 6 Weeks and 8 Weeks in Vietnam
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products · Academic / Other
- Sex
- All
- Age
- 6 Weeks – 8 Weeks
- Healthy volunteers
- Accepted
Summary
An open label study to evaluate immunogenicity, safety, and reactogenicity of Rotavac® (live attenuated oral rotavirus vaccine) as a 3-dose series in healthy infants aged between 6 weeks and 8 weeks in Vietnam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ROTAVAC® | Rotavac® is in frozen form and is thawed till fully liquid prior to administration. |
Timeline
- Start date
- 2018-02-08
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2017-12-08
- Last updated
- 2019-03-25
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT03367559. Inclusion in this directory is not an endorsement.